Terminal
Stocks
Spotlight
News

Stocks
Healthcare
NASDAQ
CRMD

Market Cap: $643.31M

CI

CorMedix Inc.

CRMD

NASDAQ (NASDAQ Global Market)USD

Overview News Analyst Reports Financials Politician Trades Insider Trades Executive Patents Earnings Surprise

Cashu

Markets

By Cashu Markets. Providing market news, analysis, and research for investors worldwide.

Company

Stocks About Cashu Markets Brokers Contact

Legal

Terms of Service Privacy Policy

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Markets is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Markets is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Markets and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Financials

Profitability

Gross Profit Margin82.78%

EBITDA Margin53.99%

EBIT Margin46.41%

Pre-tax Margin44.00%

Net Profit Margin40.49%

Earnings Yield29.10%

Valuation Multiples

Price / Book1.40

Price / Sales1.39

Price / Earnings3.40

PEG0.02

Forward PEG-0.04

EV / Sales1.15

EV / EBITDA2.13

EV / Operating Cash Flow2.09

EV / Free Cash Flow2.11

Price / Free Cash Flow2.56

Price / Operating Cash Flow2.53

Cash Flow & Capital

Free Cash Flow / Share$3.21

Operating Cash Flow / Share$3.24

Free Cash Flow Yield39.13%

Capex / Revenue0.48%

Capex / Operating Cash Flow0.88%

Capex / Depreciation0.16

Stock Compensation / Revenue1.66%

Dividend Payout Ratio0.00%

Dividend Yield0.00%

Liquidity & Leverage

Current Ratio2.56

Quick Ratio2.36

Cash Ratio1.37

Debt / Assets0.16

Debt / Capital0.24

Debt / Equity0.31

Long-Term Debt / Capital0.24

Debt / Market Cap22.56%

Net Debt / EBITDA-0.45

Solvency Ratio0.50

Financial Leverage1.96

Efficiency & Working Capital

Asset Turnover0.51

Fixed Asset Turnover58.87

Inventory Turnover2.06

Receivables Turnover2.87

Payables Turnover7.78

Days Sales Outstanding127.37

Days Inventory Outstanding176.89

Days Payables Outstanding46.94

Operating Cycle304.26

Cash Conversion Cycle257.32

Working Capital Turnover1.69

Returns & Quality

Return on Equity44.64%

Return on Assets20.70%

Return on Invested Capital27.87%

ROCE30.29%

Return on Tangible Assets36.30%

Operating Return on Assets25.24%

Income Quality2.07

Tax Burden0.92

Interest Burden0.95

Balance Sheet & Intrinsic Metrics

Enterprise Value$531.76M

Invested Capital$689.48M

Working Capital$293.16M

Tangible Asset Value$72.36M

Net Current Asset Value$37.34M

Graham Number$17.76

Graham Net-Net-$0.59

Book Value / Share$5.87

Tangible Book Value / Share$0.92

Cash / Share$3.27

Financial Health Scores

Piotroski Score4

Altman Z-Score2.38

Revenue$462.25M

EBIT$214.52M

Market Cap$643.31M

Working Capital$293.16M

Retained Earnings$-111.99M

Total Assets$904.05M

Total Liabilities$443.22M